Evidence map›Paper›PMID 29369056›Full record

ArticleCritical care medicine2018

Prompt Administration of Antibiotics and Fluids in the Treatment of Sepsis: A Murine Trial.

Anthony J Lewis, John E Griepentrog, Xianghong Zhang, Derek C Angus, Christopher W Seymour, Matthew R Rosengart

Abstract read
In one paragraph

Article in Critical care medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Observational
  3. Observational
  4. Review
  5. Article
  6. Autophagy induced by taurolidine protects against polymicrobial sepsis by promoting both host resistance and disease tolerance.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Translational Research: The Model Matters.Critical care medicine · 2018
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Anthony J LewisDepartment of Surgery, University of Pittsburgh, Pittsburgh, PA.
John E GriepentrogDepartment of Surgery, University of Pittsburgh, Pittsburgh, PA.
Xianghong ZhangDepartment of Surgery, University of Pittsburgh, Pittsburgh, PA.
Derek C AngusDepartment of Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA.
Christopher W SeymourDepartment of Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA.
Matthew R RosengartDepartment of Surgery, University of Pittsburgh, Pittsburgh, PA.
University of Pittsburgh · US

Funding

TRAINING IN TRAUMA AND SEPSIS RESEARCHT32GM008516 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI TIMOTHY R BILLIAR · 1994 to 2026
$9.4M
Sepsis subtypes: biology, treatment, and bedside applicationR35GM119519 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Christopher W. Seymour · 2016 to 2026
$4.9M
CaMK: Central Regulators of the response to Surgical SepsisR01GM082852 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ROSENGART, MATTHEW RANDALL · 2009 to 2020
$3.0M
Blue light protects against ischemia induced organ injuryR01GM116929 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ROSENGART, MATTHEW RANDALL · 2016 to 2019
$1.2M
NIGMS NIH HHS R01 GM082852NIGMS NIH HHS R01 GM116929NIGMS NIH HHS R35 GM119519NIGMS NIH HHS T32 GM008516
6 · The paper itself

Abstract

objectivesSepsis, the acute organ dysfunction caused by a dysregulated host response to infection, poses a serious public health burden. Current management includes early detection, initiation of antibiotics and fluids, and source control as necessary. Although observational data suggest that delays of even a few hours in the initiation of antibiotics or IV fluids is associated with survival, these findings are controversial. There are no randomized data in humans, and prior animal studies studied time from experimental manipulation, not from the onset of clinical features of sepsis. Using a recently developed murine cecal ligation and puncture model that precisely monitors physiologic deterioration, we hypothesize that incremental hourly delays in the first dose of antibiotics, in the first bolus of fluid resuscitation, or a combination of the two at a clinically relevant point of physiologic deterioration during polymicrobial sepsis will shorten survival.

designRandomized laboratory animal experimental trial.

settingUniversity basic science laboratory. SUBJECTS: Male C57BL/6J, female C57BL/6J, aged (40-50 wk old) male C57BL/6J, and BALB/C mice.

interventionsMice (n = 200) underwent biotelemetry-enhanced cecal ligation and puncture and were randomized after meeting validated criteria for acute physiologic deterioration. Treatment groups consisted of a single dose of imipenem/cilastatin, a single bolus of 30 mL/kg fluid resuscitation, or a combination of the two. Mice were allocated to receive treatment at the time of meeting deterioration criteria, after a 2-hour delay or after a 4-hour delay. MEASUREMENTS AND MAIN

resultsHourly delays in the initiation of antibiotic therapy led to progressively shortened survival in our model (p < 0.001). The addition of fluid resuscitation was unable to rescue animals, which received treatment 4 hours after meeting enrollment criteria. Systemic inflammation was increased, and host physiology was increasingly deranged with hourly delays to antibiotics.

conclusionsWe conclude that antibiotic therapy is highly time sensitive, and efforts should be made to deliver this critical therapy as early as possible in sepsis, perhaps extending into the first point of medical contact outside the hospital.

Indexed as

AnimalsAnti-Bacterial AgentsCytokinesDisease Models, AnimalFemaleFluid TherapyMaleMiceMice, Inbred BALB CMice, Inbred C57BLSepsisTime FactorsAnti-Bacterial AgentsCytokines

Identifiers

PMID29369056
PMCPMC5899032
OpenAlexW2789817357

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.